Testing effectiveness (Phase 2)Study completedNCT04596319
What this trial is testing
Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis
Who this might be right for
Cystic FibrosisPseudomonas AeruginosaPseudomonas+2 more
Armata Pharmaceuticals, Inc. 29